NCT05759728 2026-01-13
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Carina Biotech Limited
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT05589597 2025-08-22
AUDREY
Enterome
Phase 1/2 Terminated
NCT03439462 2024-01-02
Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Aadi Bioscience, Inc.
Phase 1/2 Completed
NCT04368507 2022-11-14
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
CellabMED
Phase 1/2 Completed
NCT03531632 2022-02-08
MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer
MacroGenics
Phase 1/2 Completed
NCT01955629 2016-04-18
AMOR
Sanofi
Phase 1/2 Terminated